Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo Grimmer

Showing results (161-170 of 186) with videos related to

Pageof 19
Sort By:
Molecular Psychiatry|July 26, 2023
Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathiesAnika Finze, Gloria Biechele, Boris-Stephan Rauchmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 7, 2017
The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium studyPaolo Bosco, Alberto Redolfi, Martina Bocchetta, et al.
The Journal of Prevention of Alzheimer'S Disease|July 10, 2025
Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s diseaseFrank Jessen, Javier Arbizu, Mercé Boada, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trialStephen Macfarlane, Timo Grimmer, Ken Teo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 25, 2019
Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementiaLieke H H Meeter, Rebecca M E Steketee, Dina Salkovic, et al.
JAMA|May 20, 2015
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysisRik Ossenkoppele, Willemijn J Jansen, Gil D Rabinovici, et al.
Annals of Neurology|September 27, 2018
Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasiaDavid Bergeron, Maria L Gorno-Tempini, Gil D Rabinovici, et al.
JAMA Network Open|May 17, 2023
Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease, Jiao Luo, Jesper Qvist Thomassen, et al.
Nature Communications|July 21, 2025
Machine learning in Alzheimer's disease geneticsMatthew Bracher-Smith, Federico Melograna, Brittany Ulm, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2018
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's diseaseNiklas Mattsson, Colin Groot, Willemijn J Jansen, et al.
Pageof 19

Showing results (161-170 of 186) with videos related to

Sort By:
Pageof 19
Molecular Psychiatry|July 26, 2023
Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathiesAnika Finze, Gloria Biechele, Boris-Stephan Rauchmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 7, 2017
The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium studyPaolo Bosco, Alberto Redolfi, Martina Bocchetta, et al.
The Journal of Prevention of Alzheimer'S Disease|July 10, 2025
Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s diseaseFrank Jessen, Javier Arbizu, Mercé Boada, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trialStephen Macfarlane, Timo Grimmer, Ken Teo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 25, 2019
Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementiaLieke H H Meeter, Rebecca M E Steketee, Dina Salkovic, et al.
JAMA|May 20, 2015
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysisRik Ossenkoppele, Willemijn J Jansen, Gil D Rabinovici, et al.
Annals of Neurology|September 27, 2018
Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasiaDavid Bergeron, Maria L Gorno-Tempini, Gil D Rabinovici, et al.
JAMA Network Open|May 17, 2023
Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease, Jiao Luo, Jesper Qvist Thomassen, et al.
Nature Communications|July 21, 2025
Machine learning in Alzheimer's disease geneticsMatthew Bracher-Smith, Federico Melograna, Brittany Ulm, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2018
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's diseaseNiklas Mattsson, Colin Groot, Willemijn J Jansen, et al.
Pageof 19